Home/ Stocks/ PTN

Palatin Technologies, Inc. Common Stock

PTN XNAS

$10.00 -0.07 (-0.68%) ▼ 15-min delayed

Open

$10.79

High

$10.79

Low

$9.81

Volume

33.3K

Market Cap

$18.27M

About Palatin Technologies, Inc. Common Stock

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 29 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2026	$3.92M	$-1,432,987	$-0.37
Q2 2026	$116.0K	$-7,263,861	$-2.86
Q3 2025	$0	$-4,811,420	N/A
Q2 2025	$0	$-2,442,482	$-0.12

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 11, 2026

Calendar →

Related Market News

No specific coverage for PTN yet. Check out our latest market news or earnings calendar.

Get PTN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Palatin Technologies, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.